How to improve outcome in high-risk stage III colon cancer with dMMR geneANNALS OF ONCOLOGYIF65.42023-06-010OA
Circulating tumor DNA could have impact on risk assessment and personalizing adjuvant therapy in localized colon cancerANNALS OF ONCOLOGYIF65.42023-06-010OA
Prognostic value of mTOR expression and mismatch repair gene profile in advanced gastric and gastro-oesophageal cancerANNALS OF ONCOLOGYIF65.42022-06-010OA
Anti-EGFR antibodies may get benefit as first-line treatment in metastatic right-sided colon cancerANNALS OF ONCOLOGYIF65.42022-06-010OA
Suggested Modifications to the Management of Patients With Breast Cancer During the COVID-19 Pandemic: Web-Based Survey StudyJMIR CANCERIF2.72021-11-152OA
Repurposing metformin as an anticancer drug: Preliminary results of randomized controlled trial in advanced prostate cancer (MANSMED)ANNALS OF ONCOLOGYIF65.42020-09-014OAAI
Prognostic value of mTOR expression and mismatch repair gene profile in advanced gastric and gastro-oesophygeal cancerANNALS OF ONCOLOGYIF65.42020-07-010OAAI
CLINICAL IMPACT OF BREAST CANCER STEM CELLS IN METASTATIC BREAST CANCER PATIENTSBREASTIF7.92019-11-011PREAI
Prognostic impact of breast cancer stem cells in metastatic breast cancer Egyptian patientsBREASTIF7.92019-03-010PREAI